TriLink Biotechnologies, LLC
TriLink Biotechnologies is a leading provider of nucleic acid products and services for the life sciences industry. The company specializes in the development and manufacture of high-quality RNA and DNA products for research and therapeutic applications.
Layoff history
EMPLOYEES AFFECTED PER QUARTER · HOVER FOR DETAILS
Layoff timeline
2 EVENTSTriLink Biotechnologies, LLC, a nucleic acid contract development and manufacturing organization (CDMO), has laid off 90 employees in California as part of a restructuring effort initiated by its parent company, Maravai. This decision reflects the company's strategic adjustments to enhance operational efficiency amid changing market conditions. The layoffs are part of a broader trend within the biotechnology sector, where companies are reevaluating their workforce to align with current demands. The affected employees were notified of their termination on October 1, 2023, marking a significant reduction in the company's workforce.
Stories from here
No one has shared a story from TriLink Biotechnologies yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for TriLink Biotechnologies
We'll email you the moment a new layoff is reported here.